MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0001168
Ramis Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹21.59 Cr
▲ 192% YoY
Net profit · FY 2024
₹47.06 Lakh
Net margin 2.2%
EBITDA · FY 2024
₹4.25 Cr
EBITDA margin 19.7%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.51 Cr
Issued & subscribed
Open charges
₹22.38 Cr
Satisfied ₹14.77 Cr
Company age
19 yrs
Est. 2007
Directors on board
2
As per MCA filings
About Ramis Laboratories Private Limited
Data last updated:
Ramis Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 19 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC055590. Its GSTIN is 36AADCB8504A1Z6 (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.51 Cr. It was formerly known as Bondbay Pharmaceuticals Private Limited. It is led by directors Sridhara Reddy Gandra and Venkata Rami Reddy Goli.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.59 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹47.06 Lakh (net margin 2.2%) and EBITDA of ₹4.25 Cr (EBITDA margin 19.7%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years and 76% over five years.
The company is associated with 1 brand: Bondbay Pharmaceuticals. As per MCA filings, the company has open charges of ₹22.38 Cr and satisfied charges of ₹14.77 Cr on record. Court records list 20 cases involving the company, including 2 filed by the company and 18 filed against it; 19 cases are pending. The company has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in January 2022. Its 5 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Yegna Manojavam Drugs & Chemicals Limited with revenue of ₹23.07 Cr.
Ramis Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0001168). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ramislabs.com.
Company details
CIN U24232TG2007PTC055590
Registration Number 055590
Incorporation Date 19 September 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0001168
CIN history
Ramis Laboratories has one previous CIN (Corporate Identification Number): U24232AP2007PTC055590. The current CIN is U24232TG2007PTC055590, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2007PTC055590 | Current |
| U24232AP2007PTC055590 | Previous |
Recognitions & Rankings of Ramis Laboratories
Contact details
Ramis Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is ramislabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.113&114 2nd Floor Alep Industrial Estate Near Pragathi Nagar Gajularamaram(Villag, E), Hyderabad, Telangana, India – 500055
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Ramis Laboratories Private Limited, buy the company report.
Comprehensive company report
Ramis Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ramis Laboratories operates one associated brand: Bondbay Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical raw materials, drug intermediates, and APIs for industry supply. | bondbaypharma.com |
Business activity
The main business activity of Ramis Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ramis Laboratories Private Limited, buy the company report.
Financials of Ramis Laboratories Private Limited
FY 2024 filings availableRamis Laboratories Private Limited reported revenue of ₹21.59 Cr (up 192% YoY) for FY 2024.
Revenue · FY 2024
₹21.59 Cr ▲ 192%
Net profit · FY 2024
₹47.06 Lakh margin 2.2%
EBITDA · FY 2024
₹4.25 Cr margin 19.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 192%
3 years · compounded
▲ 52%
5 years · compounded
▲ 76%
EBITDA CAGR growth
1 year
▲ 138%
3 years · compounded
▲ 139%
5 years · compounded
▲ 96%
Revenue has grown at a compounded annual rate (CAGR) of 76% over five years, including 192% growth in the latest year. EBITDA rose 138% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.25 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47.06 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.7% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ramis Laboratories Private Limited, buy the company report.
Board of directors of Ramis Laboratories Private Limited
Ramis Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridhara Reddy Gandra Also directs: Muralle Business Services Private Limited | Director | 20 Apr 2010 | 16 Years 6 Months | Current |
| Venkata Rami Reddy Goli | Director | 19 Sep 2007 | 19 Years 1 Months | Current |
Peer comparison
Ramis Laboratories Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yegna Manojavam Drugs & Chemicals Limited | ₹23.07 Cr (FY 2018) | 32.0% | Hyderabad, Telangana, India | |||
| Kekule Life Sciences Limited | ₹22.9 Cr (FY 2024) | 33.0% | Hyderabad, Telangana, India | |||
| Ramis Laboratories Private Limitedthis company | ₹21.59 Cr (FY 2024) | ₹47.06 Lakh | 2.2% | 192.0% | Hyderabad, Telangana, India | |
| Avance Healthcare Private Limited | ₹21.12 Cr (FY 2025) | 19.0% | Rajkot, Gujarat, India | |||
| Vav Life Sciences Private Limited | ₹20.87 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Anphar Laboratories Private Limited | ₹20.75 Cr (FY 2025) | 27.0% | Jammu, Jammu and Kashmir, India |
To see the full peer comparison of Ramis Laboratories Private Limited, buy the company report.
Auditor
Ramis Laboratories Private Limited is audited by MSPR & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSPR & CO | FY 2022 | 010152S |
Shareholding
The shareholding of Ramis Laboratories Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ramis Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹22.38 Cr
Satisfied charges
₹14.77 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Dec 2023 | 100841389 | Hdfc Bank Limited | ₹20.43 Cr | Open | |
| 19 Oct 2023 | 100813454 | Axis Bank Limited | ₹57 Lakh | Open | |
| 28 Feb 2022 | 100545899 | Karnataka Bank Ltd. | ₹1 Cr | Open | |
| 23 Nov 2021 | 100505220 | Karnataka Bank Ltd. | ₹38 Lakh | Open | |
| 15 Apr 2023 | 100726530 | Karnataka Bank Ltd. | ₹4 Cr | Satisfied |
To see the full charge records of Ramis Laboratories Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Ramis Laboratories Private Limited has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in January 2022.
Total deals
6
Secondary share transfers
4
Rights issue
1
Funding round
1
Disclosed funding
₹25.5 Lakh
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2022 | Rights issue | ₹2.2 Cr | Investors: 3 individuals |
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| May 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2014 | Funding round | ₹25.5 Lakh | Investors: 4 individuals |
To see the full deal history of Ramis Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ramis Laboratories Private Limited has 20 court cases on record: 2 filed by Ramis Laboratories, 18 filed against it. 19 cases are pending and 1 is disposed.
Total cases
20
Filed by the company
2
Filed against the company
18
Pending
19
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 20 | 18 | 19 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by Bizcovery Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by M/S. Leo Chemo Plast Pvt. Ltd. Through Shri. Rishikesh Maruti Pokale | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Sampatti New Life Private Limited Through Mr Saumil Ramesh Khona | Pending |
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed against the company by Magnesia Chemicals LLP Through Its Vice President Sales and Marketing Mr Mathews Jacob | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Ramis Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ramis Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ramis Laboratories has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCB8504A1Z6 | Telangana | Active | 01 Jul 2017 |
| 29AADCB8504A2Z0 | Karnataka | Active | 02 Feb 2021 |
To see the full GST registrations and return filing status of Ramis Laboratories Private Limited, buy the company report.
Recent activity
Ramis Laboratories Private Limited has 5 board changes on record since 2007: 2 appointments and 3 cessations. The latest: Sreedhar Tirumala ceased to be Director on 12 Aug 2017.
AGM
Ramis Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Ramis Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited of Rs. 20.43 Cr registered on 28 Dec 2023 with Charge ID 100841389 was modified on 20 Jan 2024.
Charges
A charge registered on 15 Apr 2023 via Charge ID 100726530 with Karnataka Bank Ltd. was fully satisfied on 11 Jan 2024.
Charges
A charge registered on 30 Apr 2022 via Charge ID 100565221 with Karnataka Bank Ltd. was fully satisfied on 11 Jan 2024.
Charges
A charge registered on 28 Feb 2022 via Charge ID 100545889 with Karnataka Bank Ltd. was fully satisfied on 11 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.43 Cr with Charge ID 100841389 was registered on 28 Dec 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.57 Cr with Charge ID 100813454 was registered on 19 Oct 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 4.00 Cr with Charge ID 100726530 was registered on 15 Apr 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 0.13 Cr with Charge ID 100565221 was registered on 30 Apr 2022.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 1.00 Cr with Charge ID 100545899 was registered on 28 Feb 2022.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 9.00 Cr with Charge ID 100545889 was registered on 28 Feb 2022.
12 earlier events are in the company report.
Frequently asked questions
Ramis Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 19 September 2007 (19+ years old) and is registered under CIN U24232TG2007PTC055590.
Ramis Laboratories has 2 current directors:
- Sridhara Reddy Gandra - Director
- Venkata Rami Reddy Goli - Director
The latest financial statements of Ramis Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Ramis Laboratories is 36AADCB8504A1Z6, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 29AADCB8504A2Z0 (Karnataka).
The CIN (Corporate Identification Number) of Ramis Laboratories is U24232TG2007PTC055590. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ramis Laboratories has 20 court cases on record: 2 filed by the company and 18 filed against it. 19 are pending.
Ramis Laboratories was incorporated on 19 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ramis Laboratories has 6 deals on record (4 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in January 2022.
The peers of Ramis Laboratories by revenue are Yegna Manojavam Drugs & Chemicals Limited, Kekule Life Sciences Limited, Avance Healthcare Private Limited, Vav Life Sciences Private Limited, Anphar Laboratories Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sreedhar Tirumala ceased to be Director on 12 Aug 2017. Jyothula Sathish Kumar ceased to be Director on 24 Apr 2017. Madhavarapu Venkata Rama Rao ceased to be Director on 24 Apr 2017. Ramis Laboratories has 5 board changes on record in total.
Yes, Ramis Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0001168).